It is reported that the abnormally activated JAK2/STAT3 signaling pathway enhances the occurrence and development of HCC by promoting tumor cell proliferation, migration, invasion, angiogenesis, and apoptosis inhibition (Kang et al. 2021). Here, STAT3 is linked to neoplasm.